The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism
- 1 July 1993
- journal article
- Published by Elsevier in Metabolism
- Vol. 42 (7) , 895-901
- https://doi.org/10.1016/0026-0495(93)90066-w
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Apolipoprotein E polymorphism in health and diseasePublished by Elsevier ,2004
- Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemiaThe American Journal of Cardiology, 1990
- Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4Atherosclerosis, 1990
- Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemiaAtherosclerosis, 1990
- Common low-density lipoprotein receptor mutations in the French Canadian population.Journal of Clinical Investigation, 1990
- Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levelsHuman Genetics, 1988
- Familial hypercholesterolemia and apolipoprotein E4Atherosclerosis, 1988
- Association of the apolipoprotein E4 allele with hypercholesterolemia in apparently healthy male adults in TokyoJournal of Human Genetics, 1987
- Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial HypercholesterolemiaNew England Journal of Medicine, 1987